---
brand_name: "HYDROCODONE BITARTRATE AND ACETAMINOPHEN"
generic_name: "ACETAMINOPHEN; HYDROCODONE BITARTRATE"
slug: "acetaminophen-hydrocodone-bitartrate-5mg-15ml-10mg-15ml"
canonical_url: "https://medichelpline.com/drug-index/acetaminophen-hydrocodone-bitartrate-5mg-15ml-10mg-15ml"
content_type: "drug_monograph"
route: "ORAL"
drug_class: "General Medications"
fda_updated_at: "2025-12-22T00:00:00.000Z"
license: "Drugs@FDA Public Domain / Informational Use"
---
# HYDROCODONE BITARTRATE AND ACETAMINOPHEN (ACETAMINOPHEN; HYDROCODONE BITARTRATE)
## Clinical Monograph Metadata
- **Canonical URL:** https://medichelpline.com/drug-index/acetaminophen-hydrocodone-bitartrate-5mg-15ml-10mg-15ml
- **Generic / Active Ingredient:** ACETAMINOPHEN; HYDROCODONE BITARTRATE
- **Brand Name:** HYDROCODONE BITARTRATE AND ACETAMINOPHEN
- **Administration Route:** ORAL
- **Pharmacological Class:** General Medications
- **FDA Data Timestamp:** 2025-12-22T00:00:00.000Z
## Primary Indication & Clinical Use
Review priority: STANDARD Marketing status: Prescription
## Monograph Summary

Approval overview HYDROCODONE BITARTRATE AND ACETAMINOPHEN is listed in Drugs@FDA under application 040834 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient ACETAMINOPHEN; HYDROCODONE BITARTRATE Form and strength SOLUTION;ORAL - 325MG/15ML;10MG/15ML Sponsor PHARM ASSOC Submission history Latest submission status date: 2025-12-22 00:00:00. Submission type: SUPPL.

## Primary Sources & FDA Regulatory Records
- [Drugs@FDA Primary Database](https://www.accessdata.fda.gov/scripts/cder/daf/) (Reference Slug: `acetaminophen-hydrocodone-bitartrate-5mg-15ml-10mg-15ml`)
## Navigation
- [← Back to Drug Index Hub](https://medichelpline.com/drug-index.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.